Sickle Cell Awareness Month: Understanding the science and the impact on patients
National Sickle Cell Awareness Month, observed each September, offers a time to learn about a genetic blood disorder called sickle cell disease.
Backpacks and back health: What parents and students should know this school year
Aki S. Puryear, professor of clinical orthopaedic surgery, shares key takeaways you can use to protect against backpack-related injuries.
Wells Center Newsletter August 2025
August 2025 news and updates from the Herman B Wells Center for Pediatric Research.
IU researchers use patient-derived model to explore immune system issues in Barth syndrome
Using genetic data from a Riley Children’s Health patient, IU researchers identified factors that contribute to neutropenia, a dangerous blood complication frequently seen in people
Undergraduate interns dive into biomedical research at the IU School of Medicine
More than 20 undergraduates joined IU School of Medicine internships hosted by the Herman B Wells Center this summer, gaining hands-on experience in science and
Eugene C. Klatte, MD: A Tribute
Eugene C. Klatte, distinguished professor emeritus of radiology at Indiana University School of Medicine, passed away on June 19, 2025.
Epigenetic marker may provide early detection for risk of preeclampsia-related preterm birth
IU School of Medicine researchers are studying how medical professionals can make a preeclampsia diagnosis earlier and more accurately.
Division of Child Protection remembers legacies of retiring faculty members
Roberta Hibbard and Ralphs Hicks are retiring after 40 and 18 years of service to the IU School of Medicine Division of Child Protection, part
Celebrating and reflecting on 10 years of the Pediatric Critical Care Walk-a-Thon
A decade of the Pediatric Critical Care Walk-a-Thon at Riley Children’s Hospital, an affiliate of the IU School of Medicine Department of Pediatrics, has produced
New clinical trial explores bone disease drug as a potential Type 1 diabetes treatment
IU School of Medicine Researchers are co-leading a clinical trial to test whether denosumab, an FDA-approved drug for osteoporosis, can preserve insulin-producing beta cells and